[144] US Physical Therapy Inc SEC Filing

Rhea-AI Filing Summary

US Physical Therapy (USPH) reported a proposed sale of 1,792 shares of Class A common stock on the NYSE through J.P. Morgan Securities, with an aggregate market value of $155,124.48. The filing states the shares were acquired on 05/20/2025 by vesting of restricted stock grants (grants issued from 08/16/2021 to 02/24/2025) and lists an approximate sale date of 08/11/2025 with payment in cash.

Against total outstanding shares of 15,190,000, the 1,792-share notice represents about 0.0118% of the company’s shares outstanding. The filer reported no securities sold in the past three months. The form includes the required compliance representation under Rule 144 and identifies J.P. Morgan Securities LLC as the broker.

Insights

Securities Analyst

TL;DR: Routine, small-volume sale of vested restricted shares; unlikely to be material to USPH valuation or market trading.

The filing documents a sale of 1,792 shares with aggregate value $155,124.48, implying an average price of about $86.57 per share. At 0.0118% of outstanding stock, this is a de minimis transfer relative to the company’s share base and is unlikely to move the market or materially affect ownership structure. The shares were acquired via vesting of restricted grants and will be sold through J.P. Morgan Securities LLC; there were no reported sales in the prior three months.

Corporate Governance Expert

TL;DR: Filing aligns with Rule 144 disclosure requirements and includes the standard representation about material nonpublic information.

The notice is presented under Rule 144 and includes the filer’s representation that they are not aware of undisclosed material adverse information about the issuer. The transaction details the vesting origin of the shares and identifies the broker, which supports transparency and regulatory compliance for an insider or controlled holder selling newly vested shares.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	J.P. Morgan Securities LLC 575 Washington Blvd Floor 9 Jersey City NJ 07310-1616	1792	155124.48	15190000	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2025	Vesting of Restricted STock Grants - Grants issued from 08/16/2021 - 02/24/2025)	US Physical Therap (issuer)			1792	08/11/2025	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many shares is the filer proposing to sell for USPH?

The filer proposes to sell 1,792 shares of Class A common stock.

What is the aggregate market value of the proposed USPH sale?

The filing lists an aggregate market value of $155,124.48.

When were the shares acquired and how were they obtained?

The shares were acquired on 05/20/2025 by vesting of restricted stock grants (grants issued from 08/16/2021 to 02/24/2025).

What is the approximate sale date and broker for the USPH transaction?

The approximate date of sale is 08/11/2025 and the broker listed is J.P. Morgan Securities LLC.

Did the filer sell any USPH securities in the past three months?

The filing states: Nothing to Report for securities sold during the past three months.